According to Stratistics MRC, the global immunoassay market is estimated at $16.35 billion in 2015 and is expected tgrow at a CAGR of 10.9% treach $33.72 billion by 2022. Technological advancements and increasing geriatric population worldwide are some of the key factors fuelling the market growth. Increasing incidences of infectious & chronic diseases, demand for non-invasive diagnostic techniques, broad usage of immunoassays in oncology, growing need of reagents and speed, cost effectiveness & accuracy of immunoassay are additional drivers playing a key role in the growth of immunoassay market. However, execution of excise duty by the U.S. government and low detection limit are the factors limiting the market growth. Expansion of pharmaceutical and biotechnology industries in emerging regions such as Asia Pacific acts as opportunity for immunoassay market.
Browse the full report @ http://www.orbisresearch.com/reports/index/immunoassay-global-market-outlook-2015-2022 .
In 2015, Enzyme-Linked Immunosorbent Assay (ELISA) and Enzyme-linked ImmunoSpot (ELISPOT) assay dominated the global immunoassay technology market due ttheir high sensitivity and long term presence in the market. Oncology segment is witnessing a significant growth driven by the high incidence of cancer diseases. North America is anticipated tbe the largest market for immunoassay, whereas Asia Pacific and MEA are projected tgrow at a faster pace. The aging US population is supporting the market demand, since the requirement of these medical devices is higher in the elderly population.
The technological advancements, rising investments in pharmaceutical and biotechnology sector by government and corporate sector and rapidly growing healthcare market in emerging countries such as China and India are the factors favouring the market growth in this region.
Some of the key players in the global immunoassay market include Roche Diagnostics Limited, ThermFisher Scientific, Inc, Danaher Corporation, Siemens Healthcare, Becton, Dickinson And Company, Abbott Laboratories, Inc, Luminex Corporation, Bio-Rad Laboratories, Inc., Sysmex Corporation, Biomérieux SA, Ortho-Clinical Diagnostics, Inc., Alere, Inc., Qiagen NV, Meridian Life Science, Inc and Syntron Bioresearch, Inc.
Place a direct purchase order on this report @ http://www.orbisresearch.com/contact/purchase/184676 .
Rest of Europe
Rest of Asia Pacific
Rest of the World
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Request a sample to this report @ http://www.orbisresearch.com/contacts/request-sample/184676 .
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: email@example.com